At Mirvie we create precise, actionable, non-invasive tests for maternal-fetal health.
Location: United States, California, South San Francisco
Employees: 11-50
Phone: +1 650-741-6510
Total raised: $64.6M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 01.11.2021 | Synetro Gr... | synetro.co... |
| - | Khosla Ven... | khoslavent... |
| 09.08.2022 | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.08.2023 | Grant | $4.6M | - |
| 25.05.2022 | Series B | $60M | Synetro Gr... |
Mentions in press and media 9
| Date | Title | Description |
| 28.10.2023 | The urgent call for innovation and investment in maternal health | Maneesh Jain Contributor Share on X Maneesh Jain, PhD, is CEO and co-founder of Mirvie, a company pioneering the prediction of life-threatening pregnancy complications months in advance. More than 500 years ago, Leonardo da Vinci became fas... |
| 03.08.2023 | Mirvie Receives $4.6 Million Grant From The Gates Foundation To Study Preeclampsia, A Leading Cause Of Maternal Mortality Worldwide | The proprietary Mirvie RNA platform uses a simple blood test to reveal vital information about a ... [+] pregnancy’s unique biology and detect complications months before they occurMirvie |
| 14.11.2022 | 21st Century Pregnancy Care: Unleashing The Power of RNA | Dr. Alison Cowan, Practicing OB/GYN & Head of Medical Affairs at Mirvie While maternal mortality is on the rise in the U.S., pregnancy health has seen little innovation in understanding the underlying biology of disease and is ripe for ... |
| 25.05.2022 | Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Health | Investment will propel clinical and commercial development of the Mirvie RNA platform, the first to predict unexpected complications by revealing the underlying biology of each pregnancy Funders include top-tier life science, technology, an... |
| 18.05.2022 | Mirvie raises $60M to develop early preeclampsia detection and more digital health fundings | Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 17.05.2022 | Mirvie Raises $60M in Series B Funding | Mirvie, a South San Francisco, Calif.- based leader in predicting unexpected pregnancy complications, raised a total of $90m to date following the close of its Series B funding. The financing was led by Decheng Capital with additional fundi... |
| 21.05.2021 | A 26-year-old Stanford grad student created a simple test to predict which pregnancies are likely to become premature deliveries | Mira Moufarrej Photo courtesy of Stanford Bio-X Mira Moufarrej invented a blood test to predict preterm delivery up to two months before birth. The PhD student also created a test to preditc preeclampsia in the first rather than third trime... |
| 27.04.2021 | Mirvie is redefining pregnancy health by developing the first early detection RNA test to address pregnancy complications which impact 45 million women globally | SAN FRANCISCO (PRWEB) April 27, 2021 Pregnancy complications affect 45 million women globally each year, triple the rate of cancer incidence. Today there is no reliable way to identify those pregnancies at-risk. The goal of Mirvie's simple ... |
| - | Mirvie | “The Mirvie RNA platform is first to predict unexpected complications before they happen by revealing the underlying biology of each pregnancy” |